Study identifies immune-associated genes, creating a prognostic model for overall survival in acute myeloid leukemia patients.
Key Points
A 9-gene signature model improved overall survival predictions for acute myeloid leukemia patients significantly.
The model demonstrated high predictive accuracy, with area under the curve values indicating robust performance through various survival periods.
Differentially expressed immune-associated genes were identified between acute myeloid leukemia and healthy samples using transcriptome data.
Multiple independent datasets were employed to validate the prognostic model, enhancing its potential for patient stratification and personalized treatment.